SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-076493
Filing Date
2014-11-04
Accepted
2014-11-04 16:04:55
Documents
13
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19717_110q.htm 10-Q 1274402
2 EX-10.1 a14-19717_1ex10d1.htm EX-10.1 22052
3 EX-31.1 a14-19717_1ex31d1.htm EX-31.1 11959
4 EX-31.2 a14-19717_1ex31d2.htm EX-31.2 12383
5 EX-32 a14-19717_1ex32.htm EX-32 9499
12 GRAPHIC g197171ksi001.jpg GRAPHIC 3525
13 GRAPHIC g197171ksi002.jpg GRAPHIC 2374
  Complete submission text file 0001104659-14-076493.txt   8065804

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thrx-20140930.xml EX-101.INS 1312401
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20140930.xsd EX-101.SCH 52673
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20140930_cal.xml EX-101.CAL 64469
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20140930_lab.xml EX-101.LAB 493812
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20140930_pre.xml EX-101.PRE 347098
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20140930_def.xml EX-101.DEF 184927
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 141193171
SIC: 2834 Pharmaceutical Preparations